Zura Bio

Zura Bio is a clinical-stage, multi-asset biotechnology company dedicated to developing novel dual-pathway antibody medicines for the treatment of serious autoimmune and inflammatory disorders. The company’s approach—targeting two disease-driving mechanisms at once—is designed to offer potentially greater efficacy, safety, and dosing advantages over single-target treatments.

Domain

zurabio.com

Industry

Biopharma

Employees

11-50

Last Funding

$112.5M

Founded

2021

Frequently Asked Questions

What technologies does Zura Bio use?+

Zura Bio uses 19 technologies including Divi, Google Analytics, Google Tag Manager.

What industry is Zura Bio in?+

Zura Bio operates in the Biopharma industry.

Where is Zura Bio based?+

Zura Bio is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026